Psyence Biomedical Ltd. Common Shares • PBM

Capital at risk.

About Psyence Biomedical Ltd. Common Shares
Ticker
info
PBM
Trading on
info
NASDAQ
ISIN
info
CA74449F1009
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Neil Maresky M.D.
Headquarters
info
121 Richmond Street West, Toronto, ON, Canada, M5H2K1
Employees
info
12
Website
info
psyencebiomed.com
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Metrics
BasicAdvanced
Market cap
info
$2.9M
P/E ratio
info
0.1
EPS
info
$41.76
Dividend Yield
info
0.00%
Beta
info
0.22
Forward P/E ratio
info
0
EBIDTA
info
$-3.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$2.9M
Average daily volume
info
4.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0.1
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0.1
Price to sales
info
0
Price to book
info
0.43
Earnings
EPS
info
$41.76
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-3.7M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.22
52-week High
info
$341.40
52-week Low
info
$2.36
50-day moving average
info
$5.42
200-day moving average
info
$13.88
Short ratio
info
0.28
Short %
info
1.83%
Management effectiveness
ROE (TTM)
info
0.00%
ROA (TTM)
info
-54.20%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
0.7M
Float
info
0.1M
Insiders %
info
0.48%
Institutions %
info
49.69%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$4.67
-
-
Q2 • 23Beat
-$50.32
-
-
Q3 • 23Beat
$4.07
-
-
Q3 • 24Beat
$4.06
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$0.1M
∞%
Q3 • 24
$0.1M
0.00%
Q4 • 24
NaN%
0.00%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.3M
$3.5M
155.70%
Q3 • 24
$2.3M
$3.5M
155.70%
Q4 • 24
0.00%
0.00%
0.00%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0M
-
$0M
$-0M
Q4 • 23
-
-
-
-
Q3 • 24
-
-
NaN%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Psyence Biomedical Ltd. Common Shares share?
Collapse

Psyence Biomedical Ltd. Common Shares shares are currently traded for undefined per share.

How many shares does Psyence Biomedical Ltd. Common Shares have?
Collapse

Psyence Biomedical Ltd. Common Shares currently has 0.7M shares.

Does Psyence Biomedical Ltd. Common Shares pay dividends?
Collapse

No, Psyence Biomedical Ltd. Common Shares doesn't pay dividends.

What is Psyence Biomedical Ltd. Common Shares 52 week high?
Collapse

Psyence Biomedical Ltd. Common Shares 52 week high is $341.40.

What is Psyence Biomedical Ltd. Common Shares 52 week low?
Collapse

Psyence Biomedical Ltd. Common Shares 52 week low is $2.36.

What is the 200-day moving average of Psyence Biomedical Ltd. Common Shares?
Collapse

Psyence Biomedical Ltd. Common Shares 200-day moving average is $13.88.

Who is Psyence Biomedical Ltd. Common Shares CEO?
Collapse

The CEO of Psyence Biomedical Ltd. Common Shares is Dr. Neil Maresky M.D..

How many employees Psyence Biomedical Ltd. Common Shares has?
Collapse

Psyence Biomedical Ltd. Common Shares has 12 employees.

What is the market cap of Psyence Biomedical Ltd. Common Shares?
Collapse

The market cap of Psyence Biomedical Ltd. Common Shares is $2.9M.

What is the P/E of Psyence Biomedical Ltd. Common Shares?
Collapse

The current P/E of Psyence Biomedical Ltd. Common Shares is 0.1.

What is the EPS of Psyence Biomedical Ltd. Common Shares?
Collapse

The EPS of Psyence Biomedical Ltd. Common Shares is $41.76.

What is the PEG Ratio of Psyence Biomedical Ltd. Common Shares?
Collapse

The PEG Ratio of Psyence Biomedical Ltd. Common Shares is null.